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Abstract
Background: Subacromial impingement syndrome (SIS) is the most frequently recorded shoulder
disorder. When conservative treatment of SIS fails, a subacromial decompression is warranted.
However, the best moment of referral for surgery is not well defined. Both early and late referrals
have disadvantages – unnecessary operations and smaller improvements in shoulder function,
respectively. This paper describes the design of a new interdisciplinary treatment strategy for SIS
(TRANSIT), which comprises rules to treat SIS in primary care and a well-defined moment of
referral for surgery.
Methods/Design: The effectiveness of an arthroscopic subacromial decompression versus usual
medical care will be evaluated in a randomized controlled trial (RCT). Patients are eligible for
inclusion when experiencing a recurrence of SIS within one year after a first episode of SIS which
was successfully treated with a subacromial corticosteroid injection. After inclusion they will
receive injection treatment again by their general practitioner. When, after this treatment, there is
a second recurrence within a year post-injection, the participants will be randomized to either an
arthroscopic subacromial decompression (intervention group) or continuation of usual medical
care (control group). The latter will be performed by a general practitioner according to the Dutch
National Guidelines for Shoulder Problems. At inclusion, at randomization and three, six and 12
months post-randomization an outcome assessment will take place. The primary outcome measure
is the patient-reported Shoulder Disability Questionnaire. The secondary outcome measures
include both disease-specific and generic measures, and an economic evaluation. Treatment effects
will be compared for all measurement points by using a GLM repeated measures analyses.
Discussion: The rationale and design of an RCT comparing arthroscopic subacromial
decompression with usual medical care for subacromial impingement syndrome are presented. The
results of this study will improve insight into the best moment of referral for surgery for SIS.
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Shoulder disorders are encountered frequently in general
practice. In a Dutch study the cumulative incidence of
shoulder problems was estimated to be 23.1/1000
patients/year [1]. For the neck and upper extremity it was
the most commonly presented musculoskeletal com-
plaint. A differentiation between various diagnoses of
shoulder problems in general practice was presented in
another Dutch study [2]. Subacromial impingement syn-
drome (SIS) was the most frequently recorded disorder
(44%).
The primary treatment of SIS is conservative. In primary
health care a broad spectrum of conservative treatments
for SIS is available: rest, non-steroidal anti-inflammatory
drugs (NSAIDs), corticosteroid injections, physiotherapy
and manual therapy. In the Netherlands, the choice of
treatments for shoulder conditions is proposed by the
National Guidelines for Shoulder Problems, published by
the Dutch College of General Practitioners [3]. If patients
do not respond sufficiently to these nonoperative meas-
ures, referral to an orthopedic surgeon for evaluation for
(arthroscopic) subacromial decompression is recom-
mended [4]. The best moment of referral is not well
defined though, so a therapeutic dilemma for the general
practitioner exists: how many different treatments from
the spectrum of nonoperative interventions should be
repeated or tried out if previous ones have failed? And
how long should one wait for recovery before referring?
The preoperative duration of symptoms reported in differ-
ent articles published in the last two decades on surgery
for SIS is quite long, ranging from an average of 18 to 40
months [5-9]. Expert opinions advocate orthopedic refer-
ral is warranted for patients who do not respond to non-
operative measures after (three to) six months [10-13].
Moreover, several observational studies report a signifi-
cantly better outcome of surgery in patients who had a
short symptom duration compared to those who had pro-
longed symptoms before surgery [6,9]. From these studies
it seems that the moment of referral is crucial. However,
approximately 60% of the patients recover within 27
months with nonoperative measures, which has to be
taken into consideration [14]. Early surgery would there-
fore not always be appropriate because patients could
recover nonoperatively. On the other hand, late surgery
might lead to smaller improvements of shoulder function.
To improve insight, we designed an interdisciplinary treat-
ment strategy called TRANSIT (TRANSmural treatment
strategy for Subacromial ImpingemenT), which contains
rules to treat patients with SIS in primary care and a well-
defined moment of referral to an orthopedic surgeon for
arthroscopic acromioplasty. The TRANSIT outline for the
treatment of SIS will be tested in a randomized controlled
trial (RCT), comparing treatment results of participants
allocated to arthroscopic subacromial decompression
with continuation of usual medical care by the general
practitioner. The present paper reports on the content of
TRANSIT and the methodological design of this RCT.
Methods/Design
Study design
The study is designed as a randomized controlled trial to
evaluate the effectiveness of a new interdisciplinary treat-
ment strategy for SIS. Figure 1 presents the design. The
Medical Ethics Committee of University Medical Center
Groningen has approved the study design, the protocols
and the informed consent procedure. Participants are
assigned at random to the control or to the intervention
group. The follow up period after randomization is 12
months.
TRANSIT: an interdisciplinary strategy
Initially, TRANSIT follows the National Guidelines for
Shoulder Problems to diagnose and treat patients with SIS
Study design and follow-up proceduresFigure 1
Study design and follow-up procedures. Follow-up procedures. At T0, potential participants are contacted by phone. 
After informed consent is received, patients are included. At T0, T2 and T3 questionnaires will be returned by mail. At T1 and 
T4 participants visit the hospital (H.V.).Page 2 of 8
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results following a maximum of two weeks of treatment
are insufficient, therapy is continued with a subacromial
corticosteroid injection. When ineffective, this injection is
repeated within one month. In case of recurrence within
12 months after the first successful subacromial injection,
eligible patients (see "selection of participants") are asked
to participate in the study. Recurrence means patients hav-
ing pain again, having increased pain or no longer experi-
encing pain relief. Included patients will receive another
subacromial injection from their general practitioner,
which if necessary can be repeated within one month. In
case of a second recurrence within 12 months after the last
successful injection, participants will be randomized to
either an arthroscopic subacromial decompression per-
formed within four weeks or continuation of treatment by
the general practitioner according to the National Guide-
lines for Shoulder Problems. Participants who have a
recurrence more than 12 months after the last injection
will not be randomized. Patients who do not respond to
two injections within one month will not be included
either. Their long preoperative duration does not fit
within the concept of this study, in which participants
have surgery after an on average shorter-than-usual dura-
tion of symptoms.
For both NSAIDs and subacromial corticosteroid injec-
tions there is evidence of their effectiveness for SIS, albeit
for the short term (up to a nine-month period) [15,16].
The reason for repeating a subacromial injection within a
month in case of ineffectiveness is to target inaccuracy of
subacromial injections. Several studies have reported on
accuracy rates, ranging from 60 to 80% [17-20]. In addi-
tion to being a treatment, the subacromial injection con-
stitutes a diagnosis itself (Neer impingement test) [13].
The injection fluid is a mixture of a corticosteroid and a
local anesthetic (lidocaine). When a subacromial injec-
tion eliminates the pain immediately (as a result of the
injected lidocaine), it confirms the diagnosis of SIS. If the
injection does not eliminate the pain immediately, the
diagnosis might be wrong or the injection could have
been placed inaccurately. Furthermore, a positive reaction
on a subacromial injection predicts better patient recovery
following arthroscopic subacromial decompression com-
pared to patients who have a negative reaction but a con-
firmed diagnosis through imaging [21].
Setting
The trial is carried out in 50 general practices within an
area of 20 kilometers from University Medical Center Gro-
ningen (UMCG) and at the Department of Orthopedic
Surgery of UMCG. A total of 160 general practices in the
surrounding area of Groningen were sent letters inviting
them to participate in this study. Forty interested general
practitioners attended an information meeting about the
study protocol. Following a standard protocol, they were
instructed in injecting into the subacromial space, which
they subsequently practiced on phantoms and fresh-fro-
zen cadaver shoulders. Another 10 general practitioners
who could not attend the meeting were visited at their
practice to be informed about the trial.
Study population
Sample size
The aim is to include 70 participants in the study. This
number is based on the assumption that one year after
randomization 50% of the participants will have recov-
ered with conservative treatment [22,23] and 85% will
successfully recover by means of arthroscopic subacromial
decompression. The latter assumption is based on recov-
ery rates presented in earlier studies in which successful
results of arthroscopic subacromial decompression are
reported in 86 to 95% of the cases [24-26]. A power anal-
ysis has been based on the effects of these treatments on
shoulder function. In this study shoulder function will be
measured with the Shoulder Disability Questionnaire,
which is an outcome measure comparable to the instru-
ments used in the referred articles. In order to detect a clin-
ically relevant difference in shoulder function (35%
differences in means) one year after randomization
between the intervention and control group, 64 partici-
pants are needed – 32 in each group. These numbers are
based on a power (1-B) of 0.80 and a significance level of
5% (two-sided). When a dropout rate of 10% is taken into
account, 70 participants are to be included.
Selection of participants
Subjects participating in the study are recruited by the gen-
eral practitioners involved. They introduce the study to
patients who seem eligible and give interested patients a
brochure about the trial, to be read at home. After having
received consent, the general practitioners fax the name
and telephone numbers of the interested patients to the
research team. Subsequently the researcher calls the inter-
ested patients within one week. During this conversation
the aim and implications of the study are explained again
and the eligibility criteria are checked. Patients are eligible
for participation when they meet the inclusion and exclu-
sion criteria presented in Table 1.
If patients meet these criteria and wish to join the study,
an informed consent form is signed before participation
begins. The new participants receive another subacromial
corticosteroid injection from the general practitioner for
treatment of their first recurrence. If ineffective, this injec-
tion will be repeated within one month. Participants who
have a recurrence of problems within one year after the
last injection will contact their general practitioner, who
will inform the researcher by fax. Subsequently the partic-
ipant will be invited to visit the researcher at UMCG for aPage 3 of 8
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one of the two treatment groups. Participants who do not
have a recurrence within one year will not be randomized.
Randomization
Participants will be block-randomized into two groups:
surgery or usual medical care. Subsets of four participants
are made per participating general practitioner. Two par-
ticipants will be assigned to the treatment group and two
to the control group. This process is repeated as the trial
progresses. Block randomization is a method used to pre-
vent unequal treatment-group sizes [27]. In this study,
this method is used to ensure more or less equal treatment
groups per general practitioner. It prevents participants
referred by one single general practitioner from being all
treated according to usual medical care or surgery.
Sealed, opaque envelopes in subsets of four per general
practitioner are used for randomization. The envelopes
look identical and have identification for the referring
general practitioner as well as a sequential number for the
subset. A random sequence of envelopes is generated by
an independent person. The participants choose one
envelope under supervision of the researcher.
Interventions
The treatments the two study groups are assigned to are
not different from those in usual medical care. The only
difference is that the surgery group, in most cases, will
have an operation after a shorter preoperative duration of
symptoms compared to patients who fail to respond to
conservative measures in usual medical care.
The operative treatment is an arthroscopic subacromial
decompression performed within four weeks after rand-
omization. Preoperatively no imaging will be performed,
except for a shoulder radiograph. This is because the pos-
itive reactions to the previous injections have confirmed
the SIS diagnosis. The operation is carried out in day sur-
gery under general anesthesia, possibly extended with a
regional nerve block for postoperative pain reduction.
During the operation the patient is in a beach-chair posi-
tion. The arthroscopy starts with an inspection of the
glenohumeral joint, the intra-articular surface of the rota-
tor cuff and the biceps tendon. Then the endoscope is
introduced in the subacromial bursa. Subsequently the
treatment consists of a bursectomy with partial resection
of the anteroinferior part of the acromion and the cora-
coacromial ligament. If seen, tears of the rotator cuff will
be noted but not repaired – the reason being that there is
little evidence to either support or refute the efficacy of
common interventions for rotator cuff tears [28]. There-
fore, an ongoing discussion exists as to whether to operate
on tears of the rotator cuff. As most rotator cuff tears are
caused by degeneration, which is confirmed by histo-
chemical and morphometrical research [29], an operation
Table 1: Patient eligibility criteria
Inclusion criteria:
1. Pain upon abduction of the shoulder with painful arch;
2. Shoulder pain as a recurrence of an episode with a maximum duration of 12 months in which a partial or good response is achieved with 
subacromial corticosteroid injection(s);
3. A maximum duration of six months of shoulder problems prior to the first subacromial injection, possibly treated with non-steroidal anti-
inflammatory drugs (NSAIDs) and/or physiotherapy;
4. No shoulder problems for at least two years prior to the current episode of shoulder pain;
5. Men and women, aged between 30 and 60 years;
6. Being able to give an informed consent.
Exclusion criteria:
1. Shoulder girdle pain;
2. Shoulder pain not based on pain upon abduction of the shoulder;
3. Signs of cervical root compression;
4. Bilateral shoulder pain;
5. Secondary subacromial impingement;
6. Presence of specific rheumatic diseases;
7. History of severe trauma of the shoulder within the previous two years (e.g. fracture, luxation);
8. History and/or clinical symptoms of a large rotator cuff tear;
9. Previous surgery of the affected shoulder;
10. Extrinsic causes of shoulder pain;
11. Presence of dementia or other psychiatric disorders;
12. Not being able to fill in questionnaires in Dutch.Page 4 of 8
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to be effective in the long term because of the ongoing
process of postoperative degeneration and the associated
risk of retears [30,31]. In this study, all participants have a
painful arc syndrome and a positive impingement test.
These patients can have a partial thickness rotator cuff
tear, or in the worst case a small full-thickness rotator cuff
tear. Any patients with a history and clinical symptoms of
a massive rotator cuff tear (i.e. an inability to reach over-
head, lift with an outstretched arm, and an impairment of
pushing and pulling) will be excluded. As the outcome
measures of this study focus on pain and functioning of
the shoulder and not on the integrity of the rotator cuff,
the extent of the damage, on the continuum from no tear
to a small full-thickness tear, has no consequences for the
study groups.
One senior surgeon (RLD) will undertake all procedures.
Before discharge the participant receives a sling and
instructions for daily pendulum exercises. Two weeks
post-surgery the participant visits the clinic for wound
inspection. New instructions will follow for home train-
ing exercises which focus on increasing the range of
motion of the shoulder. Four weeks later the participant
may start exercises for strengthening the rotator cuff mus-
cles. If indicated, physiotherapy can be part of the rehabil-
itation process.
The group randomized to continuation of usual medical
care will receive treatment prescribed by the general prac-
titioner according to the Guidelines for Shoulder Prob-
lems of the Dutch College of General Practitioners [3]. In
primary health care a broad spectrum of conservative
treatments for subacromial impingement syndrome is
available: rest, nonsteroidal anti-inflammatory drugs, cor-
ticosteroid injections, physiotherapy and manual therapy.
If needed, the general practitioner can also refer the partic-
ipant to a hospital of random choice for further assess-
ment and/or to be evaluated for surgery.
Outcome assessment
At inclusion (T0), at randomization (T1) and at three (T2),
six (T3) and 12 months (T4) post-randomization, out-
come assessment will take place in both study groups
(Table 2). At all measurement points, outcome will be
assessed by means of questionnaires which are sent to the
participants by mail three days earlier. At T1 and T4 the par-
ticipants are asked to visit the researcher at UMCG for an
additional physical assessment. The questionnaires
addressing those measurement moments can be filled in
at home and be handed in at the patient's visit. The
researcher checks all questionnaires for missing or incor-
rect data.
The outcome measures used focus on shoulder function,
pain and health-related quality of life. They are disease-
specific or generic, and from a patient- or physician-based
perspective. The following applied measures are disease-
specific and patient-based: the Shoulder Disability Ques-
tionnaire, the Shoulder Pain Score and the Shoulder Rat-
ing Questionnaire. The Individual Relative Constant
Score is a disease-specific as well as a patient- and physi-
cian-based instrument. The Short-form 36 Health Survey
and the Patient-perceived recovery are both generic and
patient-based. For the cost effectiveness analysis a generic,
patient-based questionnaire will be used. The specific
characteristics of the outcome measures will be men-
tioned below.
Primary outcome measure
Shoulder Disability Questionnaire (SDQ)
The SDQ is a 16-item measure for functional status limi-
tation in patients with shoulder disorders and assesses the
past 24 hours [32]. The 16 questions can be answered
with either yes, no or not applicable. The score is calcu-
lated by multiplying the yes/no ratio by 100.
Secondary outcome measures
The individual relative constant score
This shoulder assessment score is a modification of the
Constant-Murley shoulder score, in which patient-
reported subjective assessment and objective measure-
ment of shoulder function takes place at a ratio of35:65
[33]. The system is divided into subjective measures for
pain and daily activities and objective measures for range
of motion (max. 75 points) and power (max. 25 points).
The modified score contains the same items as the original
score, but uses the functional performances of the unin-
jured collateral shoulder of the same individual as a refer-
ence [34]. It is expected to be more reliable for larger and
incoherent patient populations because specific interindi-
vidual differences regarding the patient's age, gender and
constitution as well as other individual physiological
parameters are eliminated.
Table 2: Follow-up measurements
Outcome measures T0 T1 T2 T3 T4
SDQ + + + + +
SPS + + + + +
SRQ + + + + +
PPR + + + +
SF-36 + +
Cost effectiveness + + +
IRCS + +
Abbreviations used: SDQ – Shoulder Disability Questionnaire; SPS – 
Shoulder Pain Score; SRQ – Shoulder Rating Questionnaire; PPR – 
Patient-perceived recovery; SF-36 – Short-form 36; IRCS – Individual 
Relative Constant Score.Page 5 of 8
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Constant score, is performed according to a standard
method, as proposed by Bankes et al. [35]. A digital
dynamometer, the Handyscale®, is used and validated for
this application [36]. It measures a maximum of 15 kilo-
grams with two decimals and an interval of 20 grams. The
test position is the subject standing with the arm in 90°
elevation in the scapular plane, elbow extended and fore-
arm pronated. An adjustable strap is placed around the
forearm just proximal to the radiocarpal joint and
attached to the Handyscale®. The dynamometer is firmly
attached to a solid surface. The subjects are instructed to
pull upward with maximum effort until requested to stop.
The reading of the dynamometer is taken after five sec-
onds of maximum effort. For both the uninjured and the
affected arm, three successive maximum pulls will be
obtained. The highest value out of these three provides the
strength score for each arm. Patients unable to reach the
test position will receive the value of zero. The scores for
strength assessment in the Constant-Murley score range
from zero to 25 pounds, hence to calculate the individual
relative strength score the ratio of the maximum strength
scores of the affected and the unaffected arm is multiplied
by 25.
The scores for the other individual parameters range from
zero to 75 points. To calculate the individual relative sum
score for these items, the ratio of these scores for the
affected and the unaffected arm will be multiplied by 75.
The individual relative Constant score is calculated by
adding the individual relative strength score and the indi-
vidual relative sum score. The maximum attainable score
is 100 points.
The Shoulder Pain Score (SPS)
The SPS is a questionnaire to assess pain experienced by
patients with shoulder disorders and includes a 24-hour
recall frame [37]. The score consists of six pain symptom
questions and a 101-Numerical Rating Scale (NRS-101).
The SPS has been proved to be a useful instrument for fol-
lowing the course of the disorder over time, and gives an
indication when a patient feels cured. Each question
receives a maximum of four points. The NRS-101 is also
transposed to a four-point scale (0–9 = 1, 10–39 = 2, 40–
69 = 3 and 70–100 = 4). The minimum SPS score is seven
points, the maximum score 28.
Shoulder Rating Questionnaire (SRQ)
The SRQ is a self-administered patient-based instrument
which assesses shoulder function in 19 multiple-choice
questions covering seven domains [38,39]. Five subscales
are graded separately by averaging the scores of the com-
pleted questions, multiplied by two and a weighting fac-
tor. The SRQ comprises two additional dimensions
compared to the SDQ: recreational and athletic activities
and work. The sum scores range from minimum 17 to
maximum 100 points.
Short-form 36 Health Survey (SF-36)
The SF-36 is a generic health status measure. It is com-
posed of 36 questions and standardized response choices,
organized into eight multi-item scales: physical function-
ing, role limitations due to physical health problems,
bodily pain, general health perceptions, vitality, social
functioning, role limitations due to emotional problems,
and general mental health [40,41]. For purposes of this
study we used the standard version of the questionnaire,
covering a four-week time frame. All raw scale scores are
linearly converted to a zero-to-100 scale, with higher
scores indicating higher levels of functioning or well-
being.
Patient-perceived recovery (PPR)
In addition to the SF-36 there is the PPR, a one-item score
concerning recovery following treatment, measured on a
seven-point ordinal scale [42].
Cost effectiveness
An economic evaluation will be performed using a ques-
tionnaire to assess direct health care costs as well as direct
non-health related costs. The questionnaire is composed
of 24 questions regarding costs of the last six months. The
data will be used for a cost-effectiveness analysis, which
will be done by the UMCG Medical Technology Assess-
ment office.
Statistical analyses
To estimate the effect of the interventions, analyses will be
performed using SPSS 12.0 for the outcome measures. The
baseline characteristics from both study groups will be
compared for equality by means of an Independent Sam-
ples T-test (p-value 0.05) for continuous variables and a
chi-square test for dichotomous variables. To compare
treatment effects from measurement points T0 to T4, a
GLM repeated measures analyses will be performed. Data
will be analyzed according to the intention-to-treat princi-
ple and the per-protocol principle.
Discussion
TRANSIT is designed to test if early referral for surgery
leads to earlier and more complete improvement in
shoulder pain and function than continuation of usual
medical care for patients suffering from SIS. This has been
advocated in expert opinions, but has never been proven
in a randomized controlled trial.
The results of this study will improve insight into the best
moment of referral for surgery for SIS. If, in the TRANSIT
outline, participants who have had an arthroscopic subac-
romial decompression prove to have better results thanPage 6 of 8
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update of Dutch and/or international guidelines for
shoulder conditions will be needed.
The rationale and design of an RCT comparing a new
interdisciplinary treatment strategy with usual medical
care for subacromial impingement syndrome have been
presented.
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